Astrana Health, Inc. (NASDAQ:ASTH) Receives $34.86 Average Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given an average recommendation of “Moderate Buy” by the nine analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $34.8571.

A number of brokerages recently issued reports on ASTH. Truist Financial upped their target price on Astrana Health from $37.00 to $38.00 and gave the company a “buy” rating in a research report on Friday, March 13th. Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. BTIG Research decreased their target price on Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Weiss Ratings reissued a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Finally, Robert W. Baird upped their target price on Astrana Health from $37.00 to $40.00 and gave the company an “outperform” rating in a research report on Wednesday.

Institutional Trading of Astrana Health

A number of large investors have recently made changes to their positions in ASTH. Diamond Hill Capital Management Inc. lifted its position in Astrana Health by 33.0% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 361,264 shares of the company’s stock worth $10,242,000 after acquiring an additional 89,733 shares during the period. Insight Wealth Strategies LLC acquired a new position in shares of Astrana Health in the fourth quarter valued at approximately $3,514,000. Pacer Advisors Inc. purchased a new stake in shares of Astrana Health during the third quarter worth approximately $5,157,000. SteelPeak Wealth LLC raised its stake in shares of Astrana Health by 7.8% during the third quarter. SteelPeak Wealth LLC now owns 579,937 shares of the company’s stock worth $16,441,000 after purchasing an additional 41,761 shares during the last quarter. Finally, 325 Capital LLC lifted its holdings in shares of Astrana Health by 34.6% during the third quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock worth $33,849,000 after purchasing an additional 307,037 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Trading Up 2.9%

ASTH opened at $31.50 on Thursday. The company has a market cap of $1.75 billion, a P/E ratio of 68.48 and a beta of 0.77. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.40 and a current ratio of 1.40. Astrana Health has a one year low of $18.08 and a one year high of $34.80. The business’s 50-day simple moving average is $23.80 and its 200-day simple moving average is $25.34.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Monday, March 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The firm had revenue of $950.53 million during the quarter, compared to analysts’ expectations of $930.46 million. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The business’s revenue was up 42.9% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.15) EPS. As a group, equities research analysts expect that Astrana Health will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.